1. Home
  2. ACOG vs MGRM Comparison

ACOG vs MGRM Comparison

Compare ACOG & MGRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ACOG
  • MGRM
  • Stock Information
  • Founded
  • ACOG 2000
  • MGRM 2016
  • Country
  • ACOG Canada
  • MGRM United States
  • Employees
  • ACOG N/A
  • MGRM N/A
  • Industry
  • ACOG
  • MGRM Medical/Dental Instruments
  • Sector
  • ACOG
  • MGRM Health Care
  • Exchange
  • ACOG Nasdaq
  • MGRM Nasdaq
  • Market Cap
  • ACOG 80.3M
  • MGRM 79.9M
  • IPO Year
  • ACOG N/A
  • MGRM N/A
  • Fundamental
  • Price
  • ACOG $10.80
  • MGRM $3.32
  • Analyst Decision
  • ACOG Strong Buy
  • MGRM Strong Buy
  • Analyst Count
  • ACOG 1
  • MGRM 1
  • Target Price
  • ACOG $20.00
  • MGRM $5.40
  • AVG Volume (30 Days)
  • ACOG 67.2K
  • MGRM 60.8K
  • Earning Date
  • ACOG 08-14-2025
  • MGRM 08-13-2025
  • Dividend Yield
  • ACOG N/A
  • MGRM N/A
  • EPS Growth
  • ACOG N/A
  • MGRM N/A
  • EPS
  • ACOG N/A
  • MGRM N/A
  • Revenue
  • ACOG $2,928,654.00
  • MGRM N/A
  • Revenue This Year
  • ACOG N/A
  • MGRM N/A
  • Revenue Next Year
  • ACOG N/A
  • MGRM N/A
  • P/E Ratio
  • ACOG N/A
  • MGRM N/A
  • Revenue Growth
  • ACOG N/A
  • MGRM N/A
  • 52 Week Low
  • ACOG $3.75
  • MGRM $1.92
  • 52 Week High
  • ACOG $11.54
  • MGRM $4.21
  • Technical
  • Relative Strength Index (RSI)
  • ACOG N/A
  • MGRM 70.21
  • Support Level
  • ACOG N/A
  • MGRM $2.81
  • Resistance Level
  • ACOG N/A
  • MGRM $3.42
  • Average True Range (ATR)
  • ACOG 0.00
  • MGRM 0.14
  • MACD
  • ACOG 0.00
  • MGRM 0.04
  • Stochastic Oscillator
  • ACOG 0.00
  • MGRM 71.64

About ACOG Alpha Cognition Inc. Common Stock

Alpha Cognition Inc is a biopharmaceutical company dedicated to developing treatments for patients suffering from neurodegenerative diseases, such as Alzheimer's disease, for which there are limited or no treatment options. The Company's current focus is on the commercial manufacturing and sales of ZUNVEYL oral tablet formulation. The Company's commercial development program for ZUNVEYL is primarily focused on building a long-term care commercial team that can focus on providing key points of differentiation, exploiting key issues with existing Acetylcholinesterase inhibitors treatments, and seeking potential licensing partners for other additional indications and new formulations.

About MGRM Monogram Orthopaedics Inc.

Monogram Technologies Inc develops a product solution architecture to enable patient-optimized orthopedic implants at scale by linking 3D printing and robotics with advanced pre-operative imaging. The company has a robot prototype that can autonomously execute optimized paths for high-precision insertion of implants in synthetic bone specimens. Monogram also intends to produce and market robotic surgical equipment and related software, orthopedic implants, tissue ablation tools, navigation consumables, and other miscellaneous instrumentation necessary for reconstructive joint replacement procedures.

Share on Social Networks: